Close Menu

NEW YORK (GenomeWeb) – Arbor Biotechnologies and Vertex Pharmaceuticals announced today that they have partnered to discover novel proteins, including DNA endonucleases, for the development of new gene editing-based therapies for cystic fibrosis and four other diseases to be selected later.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.